Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength
Top Cited Papers
- 29 January 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6528) , 483-+
Abstract
Maintaining muscle: Prostaglandin E2 (PGE2), an eicosanoid that mediates inflammatory responses, also supports the function of muscle stem cells. Palla et al. found that loss of PGE2 in aging mice contributes to loss of muscle and appears to be a consequence of increased activity of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), an enzyme that degrades PGE2 (see the Perspective by Becker and Rudolph). Restoring PGE2 concentrations by inhibiting 15-PGDH in older mice improved muscle function. Decreased activity of 15-PGDH in older animals had beneficial effects that included decreased proteolysis and transforming growth factor–β signaling and increased mitochondrial function and autophagy. The findings reveal a potential therapeutic strategy to help maintain muscle mass and function during aging. Science , this issue p. eabc8059 ; see also p. 462Keywords
Funding Information
- National Institutes of Health (5R01AG02096115)
- National Institutes of Health (1R01AG069858-01)
- National Institutes of Health (RHG009674A)
- National Institutes of Health (K99NS120278)
- National Institutes of Health (1S10OD026962-01)
- National Institutes of Health (1S10RR026780-01)
- California Institute for Regenerative Medicine (DISC2-10604)
- Li Ka Shing Foundation
- Donald E. and Delia B. Baxter Foundation
- Swiss National Science Foundation (P2EZP3_184231)
- Swiss National Science Foundation
- Canadian Institutes of Health Research
This publication has 72 references indexed in Scilit:
- E-type prostanoid receptor 4 (EP4) in disease and therapyPharmacology & Therapeutics, 2013
- The role of myostatin in muscle wasting: an overviewJournal of Cachexia, Sarcopenia and Muscle, 2011
- Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on SarcopeniaJournal of the American Medical Directors Association, 2011
- An overview of sarcopenia: facts and numbers on prevalence and clinical impactJournal of Cachexia, Sarcopenia and Muscle, 2010
- Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin LigasesCell, 2010
- Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise trainingJournal of Cachexia, Sarcopenia and Muscle, 2010
- Eicosanoids and cancerNature Reviews Cancer, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Self-renewal and expansion of single transplanted muscle stem cellsNature, 2008
- Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasisNature, 2007